Healthcare Europa

The only information source for private healthcare services in Europe, click here to download a brochure

Medgate AI project to cut costs by 30-40%

Digital healthcare pioneer Medgate is evaluating opportunities in Germany and other European countries. A chatbot based on the 12 million telehealth sessions it has held over the past 19 years is in development and will be launched at the end of 2018 and should reduce costs by 30-40%, Medgate CEO and founder Andy Fischer tells Healthcare Nova. 

Interview: Giuseppe Recchi, CEO and Rowland Illing, CMO, Affidea

In a wide-ranging interview, we look at Affidea’s strategy and view of the market covering everything from partnerships with AI outfits, elite hospitals and payors through to the growth of private pay and the opportunities to manage entire health systems. How will the imaging services and radiotherapy group with HBI estimated sales of around €370m in 2017 grow and build over the next five years?

Medgate AI project to cut costs by 30-40%

Digital healthcare pioneer Medgate is evaluating opportunities in Germany and other European countries. A chatbot based on the 12 million telehealth sessions it has held over the past 19 years is in development and will be launched at the end of 2018 and should reduce costs by 30-40%, Medgate CEO and founder Andy Fischer tells Healthcare Europa. 

German “uber” imaging model set to soar

medneo is planning a massive expansion from its current nine centres in Germany and one in Switzerland, using its pay-per-use model. The company backed by investor Marcol claims to be doubling sales year-on-year. Co-founder and managing director Nicolas Weber says the model is disruptive, highly scalable and difficult to copy by potential followers due to its innovative IT […]

Paracelsus fails to find buyer

Paracelsus, the German and Swiss hospital and reha business has so far failed to find a buyer. Potential buyers say the group which is in the German equivalent of Chapter 11 is overpriced.

IVF/lab group sells stake to Oaktree; buys in Italy, Spain and Switzerland

NL Holding has sold a 30% stake to Oaktree Capital, while simultaneously acquiring fertility providers and specialised diagnostic laboratories in Switzerland, Italy and Spain. This coincides with Oaktree offloading its pan-European dentistry platform. We take a more detailed look at what NL has bought.